KR910007518A - 서방성 제제 - Google Patents
서방성 제제 Download PDFInfo
- Publication number
- KR910007518A KR910007518A KR1019900016857A KR900016857A KR910007518A KR 910007518 A KR910007518 A KR 910007518A KR 1019900016857 A KR1019900016857 A KR 1019900016857A KR 900016857 A KR900016857 A KR 900016857A KR 910007518 A KR910007518 A KR 910007518A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- formulation
- excipient
- agent
- hydrophilic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/2036—Silicones; Polysiloxanes
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (13)
- 제제가 수성 매질에 있을 경우 제제로부터 방출될 수 있는 약제(A) 및 친수성 성분, 탄성 실리콘 중합체 및 조절 성분을 포함하는 부형제(B)를 포함함을 특징으로 하는 서방성 제제.
- 제1항에 있어서, 친수성 성분이 프로필렌 글리콜, 액체 폴리에틸렌 글리콜 및 글리세롤 중에서 선택되고 부형제의 10 내지 30중량%로 존재함을 추가의 특징으로 하는 제제.
- 제1항 또는 제2항에 있어서, 실리콘 중합체가 알킬하이드로겐 실로산 단위를 갖는 폴리실로산 및 이와 반응할 불표화 그룹을 갖는 폴리실로산과의 백금 또는 로듐 촉매의 하이드로실릴화 반응의 생성물임을 추가의 특징으로 하는 제제.
- 제1항 내지 제3항 중 어느 한 항에 있어서, 조절 성분이 (Ⅰ)분자당2개 이상의 하이드록실기를 갖는 유기물질 또는 (Ⅱ)수성 매질 중에 팽창되는 친수성 중합체임을 추가의 특징으로 하는 제제.
- 제4항에 있어서, 유기물질(Ⅰ)이 분자량 1500이상의 폴리에틸렌 글리콜, 소비톨, 만니톨 및 락토오즈 중에서 선택되고 부형제의 5 내지 25중량%로 존재함을 추가의 특징으로 하는 제제.
- 제4항에 있어서, 친수성 중합체(Ⅱ)가 가교결합되거나 되지않은 하이드록시프로필 셀룰로오스, 카복시메틸 셀룰로오스 및 나트륨 카복시 메틸 셀룰로오스 중에서 선택되고 부형제의 10 내지 45중량%로 존재함을 추가의 특징으로 하는 제제.
- 제6항에 있어서, 부형제가 pH 1 내지 4의 수성 매질 중의 친수성 중합체(Ⅱ)의 팽창에 효과적인 완충염의 30중량% 이하를 포함함을 추가의 특징으로 하는 제제.
- 제1항 내지 제7항 중 어느 한 항에 있어서, 부형제가 제제의 생체 점착성에 기여하는 유기 물질을 포함함을 추가의 특징으로 하는 제제.
- 제1항 내지 제8항 중 어느 한 항에 있어서, 제제가 인체 또는 동물체에 투여되기 위해 입자, 마이크로 캡슐, 필름, 로드, 환제, 패드, 패치 또는 매트릭스임을 추가의 특징으로 하는 제제.
- 제1항 내지 제9항 중 어느 한 항에 있어서, 약제(A)가 치료제 또는 진단제이고 항생제, 방부제, 소염제, 심장 혈관제, 향수소제, 기관지 확장제, 진통제, 향부정맥제, 향히스타민제, α-1 차단제, 베타 차단제, ACE저해제, 이뇨제, 항응집제, 진정제, 정신 안정제, 항경련제 및 항응고제, 비타민, 위궤양 및 십이지장 궤양 치료제, 단백질 분해효소, 치료 요소 및 펩티드 중에서 선택됨을 특징으로 하는 치료방법 또는 진단방법에 사용되는 제제.
- 제1항에 있어서, 약제(A)가 0 내지 95, 바람직하게는 50중량부 이하이고, 친수성 성분 10 내지 35중량%, 실리콘 중합체 10 내지 60중량%, 및 가교결합되거나 되지않은 하이드록시프로필 셀룰로오스, 카복시 메틸 셀룰로오스 또는 나트륨 카복시 메틸 셀룰로오스 및 이의 혼합물중에서 선택된 조절 성분 10 내지 40중량%를 포함하는 부형제(B)가 99.50 내지 5중량부인 비율로 성분 (A) 및 (B)를 포함하는 경구투여에 적합한 형태의 제제.
- 제1항에 있어서, 약제(A)가 0.5 내지 80, 바람직하게는 40 내지 60중량부 이고, 친수성 성분 10내지 40중량% 실리콘 중합체 40 내지 80중량%, 및 분자량 1500 이상의 폴리에틸렌 글리콜, 소비톨, 만니톨 및 락토오즈 및 이의 혼합물 중에서 선택된 조절 성분 10 내지 40중량%를 포함하는 부형제(B)가 99.5 내지 40중량부인 비율로 성분 (A) 및 (B)를 포함하는 체강에 투여하기에 적합한 형태의 제제.
- 약제(A) 및 친수성 성분, 조절성분, 및 알킬하이드로겐 실록산 단위를 갖는 폴리실록산 및 이와 반응할 불포화 그룹을 갖는 폴리실록산을 포함한 백금 또는 로듐 촉매의 경화성 실리콘 조성물을 포함하는 부형제(B)를 제공하기 위해 경화가능한 제형을 혼합하고, 피복, 과립화, 성형, 압출 또는 실리콘 조성물이 경화함에 따라 혼합물을 성형시킴을 특징으로 하여 제1항 내지 12항 중 어느 한 항에 따른 제제를 제조하는 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8913818 | 1989-10-23 | ||
FR8913818A FR2653337B1 (fr) | 1989-10-23 | 1989-10-23 | Element a liberation prolongee et procede pour le fabriquer. |
Publications (1)
Publication Number | Publication Date |
---|---|
KR910007518A true KR910007518A (ko) | 1991-05-30 |
Family
ID=9386646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019900016857A KR910007518A (ko) | 1989-10-23 | 1990-10-22 | 서방성 제제 |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0425154B1 (ko) |
JP (1) | JPH03167116A (ko) |
KR (1) | KR910007518A (ko) |
AU (1) | AU639947B2 (ko) |
BR (1) | BR9005223A (ko) |
CA (1) | CA2027865A1 (ko) |
DE (1) | DE69003347T2 (ko) |
DK (1) | DK0425154T3 (ko) |
ES (1) | ES2044451T3 (ko) |
FI (1) | FI905195A0 (ko) |
FR (1) | FR2653337B1 (ko) |
HU (1) | HUT69395A (ko) |
IE (1) | IE66826B1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100477364B1 (ko) * | 2002-07-03 | 2005-03-22 | 주식회사 메디켐스 | 신규한 헬리코박터 파이로리 균 진단용 13c-요소 캅셀 제제 |
KR20150114174A (ko) | 2014-04-01 | 2015-10-12 | 주식회사 명성 | 스크루식 뚜껑 성형장치 |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5721365A (en) * | 1989-09-15 | 1998-02-24 | Us Health | N-substituted piperazine NONOates |
US5208233A (en) * | 1989-09-15 | 1993-05-04 | The United States Of America As Represented By The Department Of Health And Human Services | Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof |
FR2677253A1 (fr) * | 1991-06-07 | 1992-12-11 | Union Metropolitaine Pharmaceu | Composition therapeutique utile vis-a-vis des maladies inflammatoires du systeme gastro-intestinal. |
JP3190340B2 (ja) * | 1991-09-24 | 2001-07-23 | アメリカ合衆国 | 酸化窒素供与体プロドラッグとしての求核試薬−酸化窒素付加物の酸素置換誘導体 |
US5405919A (en) * | 1992-08-24 | 1995-04-11 | The United States Of America As Represented By The Secretary Of Health And Human Services | Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders |
US5691423A (en) * | 1992-08-24 | 1997-11-25 | The United States Of America As Represented By The Department Of Health And Human Services | Polysaccharide-bound nitric oxide-nucleophile adducts |
US5910316A (en) | 1992-08-24 | 1999-06-08 | The United States Of America, As Represented By The Department Of Health And Human Services | Use of nitric oxide-releasing agents to treat impotency |
US6200558B1 (en) | 1993-09-14 | 2001-03-13 | The United States Of America As Represented By The Department Of Health And Human Services | Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
US5525357A (en) * | 1992-08-24 | 1996-06-11 | The United States Of America As Represented By The Department Of Health And Human Services | Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
US5714511A (en) * | 1995-07-31 | 1998-02-03 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs |
FR2752380B1 (fr) * | 1996-08-14 | 1998-10-30 | Dow Corning Sa | Procede de fabrication d'un dispositif a liberation controlee |
US6261594B1 (en) | 1998-11-25 | 2001-07-17 | The University Of Akron | Chitosan-based nitric oxide donor compositions |
US6432448B1 (en) | 1999-02-08 | 2002-08-13 | Fmc Corporation | Edible coating composition |
US6723342B1 (en) | 1999-02-08 | 2004-04-20 | Fmc Corporation | Edible coating composition |
US6500462B1 (en) | 1999-10-29 | 2002-12-31 | Fmc Corporation | Edible MCC/PGA coating composition |
IL155959A0 (en) | 2000-11-28 | 2003-12-23 | Fmc Corp | Edible pga (propylene glycol alginate) coating composition |
PA8578501A1 (es) | 2002-07-25 | 2005-02-04 | Pharmacia Corp | Forma de dosificacion una vez al dia de pramipexol |
CA2576386A1 (en) | 2004-08-13 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
BRPI0513846A (pt) | 2004-08-13 | 2008-05-20 | Boehringer Ingelheim Int | formulação de comprimido de liberação prolongada contendo pramipexol ou um sal farmaceuticamente aceitável do mesmo, método para a fabricação do mesmo e o uso do mesmo |
DE602005007205D1 (de) * | 2005-07-19 | 2008-07-10 | Ethypharm Sa | Gastroretentive Zusammensetzungen und Verfahren zur Herstellung |
WO2007086078A2 (en) * | 2006-01-30 | 2007-08-02 | Panacea Biotec Ltd. | Novel pharmaceutical compositions and process of preparation thereof |
GB0909680D0 (en) | 2009-06-05 | 2009-07-22 | Euro Celtique Sa | Dosage form |
EP2558132B1 (en) | 2010-04-14 | 2020-10-14 | Mölnlycke Health Care AB | Antimicrobial gels |
CA2798884C (en) | 2010-05-10 | 2016-09-13 | Euro-Celtique S.A. | Manufacturing of active-free granules and tablets comprising the same |
US9901540B2 (en) | 2010-05-10 | 2018-02-27 | Euro-Celtique S.A. | Combination of active loaded granules with additional actives |
SE1251371A1 (sv) | 2010-05-10 | 2012-12-27 | Euro Celtique Sa | Farmaceutiska kompositioner innefattande hydromorfon och naloxon |
GB201020895D0 (en) | 2010-12-09 | 2011-01-26 | Euro Celtique Sa | Dosage form |
BR112016009749A8 (pt) | 2013-11-13 | 2018-01-30 | Euro Celtique Sa | hidromorfona e naloxona para tratamento de dor e síndrome de disfunção intestinal opioide |
LT4037666T (lt) | 2020-12-08 | 2024-06-10 | Ruminant Biotech Corp Limited | Medžiagų pristatymo gyvūnams prietaisų ir būdų patobulinimai |
WO2023148316A1 (en) * | 2022-02-03 | 2023-08-10 | Basf Se | Magnesium diacetate x 4h 2o and/or magnesium dichloride x 6h 2o and/or magnesium sulfate x 7h 2o and/or disodium sulfate x 10 h 2o and/or sodium thiosulfate x 5h 2o and/or na 3po 4 x 12 h 2o and/or na 2hpo 4 x 12h 2o/7h 2o and/or sodium acetate x 3h 2o as granulating aid |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE791632A (fr) * | 1971-11-20 | 1973-05-21 | Schering Ag | Supports a base de caoutchouc siliconique pour agents medicamenteux |
US3991750A (en) * | 1975-04-28 | 1976-11-16 | Syntex Corporation | Dromostanolone propionate implant pellet useful for producing weight gains in animals and suppressing estrus in female animals |
SE8203953D0 (sv) * | 1982-06-24 | 1982-06-24 | Astra Laekemedel Ab | Pharmaceutical mixture |
CA1331338C (en) * | 1987-02-03 | 1994-08-09 | Dow Corning Corporation | Aqueous film-forming compositions for controlling the release of active agents and process of making same |
FR2610827B1 (fr) * | 1987-02-18 | 1991-09-13 | Pf Medicament | Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication |
GB8704755D0 (en) * | 1987-02-28 | 1987-04-01 | Dow Corning Ltd | Pharmaceutical delivery device |
-
1989
- 1989-10-23 FR FR8913818A patent/FR2653337B1/fr not_active Expired - Lifetime
-
1990
- 1990-10-16 ES ES90311278T patent/ES2044451T3/es not_active Expired - Lifetime
- 1990-10-16 EP EP90311278A patent/EP0425154B1/en not_active Expired - Lifetime
- 1990-10-16 DE DE90311278T patent/DE69003347T2/de not_active Expired - Fee Related
- 1990-10-16 DK DK90311278.7T patent/DK0425154T3/da active
- 1990-10-17 CA CA002027865A patent/CA2027865A1/en not_active Abandoned
- 1990-10-17 BR BR909005223A patent/BR9005223A/pt not_active Application Discontinuation
- 1990-10-20 HU HU906525A patent/HUT69395A/hu unknown
- 1990-10-22 KR KR1019900016857A patent/KR910007518A/ko not_active Application Discontinuation
- 1990-10-22 IE IE377790A patent/IE66826B1/en not_active IP Right Cessation
- 1990-10-22 AU AU64863/90A patent/AU639947B2/en not_active Ceased
- 1990-10-22 FI FI905195A patent/FI905195A0/fi not_active Application Discontinuation
- 1990-10-23 JP JP2285678A patent/JPH03167116A/ja active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100477364B1 (ko) * | 2002-07-03 | 2005-03-22 | 주식회사 메디켐스 | 신규한 헬리코박터 파이로리 균 진단용 13c-요소 캅셀 제제 |
KR20150114174A (ko) | 2014-04-01 | 2015-10-12 | 주식회사 명성 | 스크루식 뚜껑 성형장치 |
Also Published As
Publication number | Publication date |
---|---|
IE903777A1 (en) | 1991-04-24 |
BR9005223A (pt) | 1991-09-17 |
EP0425154A1 (en) | 1991-05-02 |
HUT69395A (en) | 1995-09-28 |
FI905195A0 (fi) | 1990-10-22 |
DK0425154T3 (da) | 1993-11-01 |
EP0425154B1 (en) | 1993-09-15 |
DE69003347T2 (de) | 1994-02-17 |
IE66826B1 (en) | 1996-02-07 |
AU639947B2 (en) | 1993-08-12 |
AU6486390A (en) | 1991-04-26 |
JPH03167116A (ja) | 1991-07-19 |
CA2027865A1 (en) | 1991-04-24 |
FR2653337A1 (fr) | 1991-04-26 |
FR2653337B1 (fr) | 1992-02-07 |
HU906525D0 (en) | 1991-04-29 |
DE69003347D1 (de) | 1993-10-21 |
ES2044451T3 (es) | 1994-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR910007518A (ko) | 서방성 제제 | |
KR910007508A (ko) | 서방출 드레싱용 제제 및 이의 용도 | |
US4695464A (en) | Sustained release dosage form based on highly plasticized cellulose ether gels | |
ES2325046T3 (es) | Formulacion farmaceutica extruible por fusion en caliente. | |
CA1236009A (en) | Sustained release dosage form based on highly plasticized cellulose ether gels | |
US4230686A (en) | Drug excipient of silicone rubber | |
AU731645B2 (en) | Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues | |
JP3964465B2 (ja) | 粘膜表面への、薬学的化合物の送達に適する薬学的キャリアデバイス | |
US5876754A (en) | Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies | |
RU2242969C2 (ru) | Быстро диспергируемые лекарственные формы, содержащие рыбий желатин | |
HUP9904174A2 (hu) | Bőrön át történő adagoláshoz szánt gyógyszerkészítmények | |
EP1212091B1 (en) | Polyoxyalkylene copolymers containing pourable liquid vehicles | |
US20020048601A1 (en) | Suppository and composition comprising at least one polyethylene glycol | |
AU6627886A (en) | Film-forming, pharmaceutical vehicles for application of medicaments to nails, pharmaceutical compositions based on those vehicles, and methods of using same | |
KR950007841A (ko) | 트라마돌 염을 함유하는 서방성 약물 제제 | |
JP2009518405A (ja) | 活性物質の送達のための局所フィルム組成物 | |
HU210926B (en) | Process to prepare crosslinked hyaluronic acid derivs. and pharmaceutical compns. contg. them and cosmetics contg. them | |
KR960021032A (ko) | 연성 젤라틴 약제학적 용량형 | |
DE69932905D1 (de) | Arzneimittel zur verabreichung auf schleimhäute | |
SE442167B (sv) | Lagringsstabilt prostaglandin innehallande medicinskt preparat | |
Mojsiewicz‐Pieńkowska | Review of current pharmaceutical applications of polysiloxanes (Silicones) | |
SE9704401D0 (sv) | Matrix pellets for greasy, oily or sticky drug substances | |
ATE156350T1 (de) | Peptidarzneistoffe enthaltende pellets und ihre herstellung sowie deren verwendung | |
JP2009521532A (ja) | 活性物質を放出するための、pH調節されたフィルム | |
KR100885178B1 (ko) | 점착성 약제 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |